##4080446
A	a	zz1
91/2-year-old		fu
girl	girl	nn1
presented	present	vvn_vvd
with	with	iw
a	a	at1
2-month	2-month	jj_nnt1
history	history	nn1
of	of	io
painful	painful	jj
aural	aural	jj
fullness	fullness	nn1
bilaterally	bilaterally	rr
,	,	y
rotary	rotary	jj_nn1
vertigo	vertigo	nn1
,	,	y
nausea	nausea	nn1
,	,	y
and	and	cc
severe	severe	jj
headache	headache	nn1
.	.	y
She	she	pphs1
was	be	vbdz
generally	generally	rr
symptom-free	symptom-free	jj_rr@
when	when	cs_rrq
she	she	pphs1
awoke	awake	vvd
in	in	ii
the	the	at
morning	morning	nnt1
,	,	y
and	and	cc
she	she	pphs1
experienced	experience	vvd
only	only	rr_jj
minor	minor	jj
symptoms	symptom	nn2
during	during	ii
the	the	at
day	day	nnt1
.	.	y
However	however	rr
,	,	y
her	her	appge
symptoms	symptom	nn2
typically	typically	rr
intensified	intensify	vvn_vvd
after	after	ii
dinner	dinner	nn1
and	and	cc
persisted	persist	vvn
into	into	ii
the	the	at
evening	evening	nnt1
.	.	y
The	the	at
ear	ear	nn1
pain	pain	nn1
was	be	vbdz
followed	follow	vvn
by	by	ii
10-minute	10-minute	jj
episodes	episode	nn2
of	of	io
vertigo	vertigo	nn1
,	,	y
which	which	ddq
were	be	vbdr
followed	follow	vvn
in	in	ii
turn	turn	nn1
by	by	ii
bifrontal	bifrontal	jj
headaches	headache	nn2_vvz
that	that	cst
extended	extend	vvd
down	down	rp
to	to	ii
the	the	at
maxillary	maxillary	jj_nn1
sinuses	sinus	nn2_vvz
.	.	y
The	the	at
intensity	intensity	nn1
of	of	io
the	the	at
dizziness	dizziness	nn1
varied	vary	vvd_vvn
,	,	y
and	and	cc
when	when	cs_rrq
it	it	pph1
was	be	vbdz
severe	severe	jj
,	,	y
it	it	pph1
would	would	vm
lead	lead	vvi
to	to	ii
nausea	nausea	nn1
.	.	y
Neither	neither	rr
the	the	at
ear	ear	nn1
pain	pain	nn1
nor	nor	cc
the	the	at
headaches	headache	nn2
were	be	vbdr
relieved	relieve	vvn
by	by	ii
ibuprofen	ibuprofen	nn1_jj
,	,	y
although	although	cs
the	the	at
dizziness	dizziness	nn1
was	be	vbdz
eased	ease	vvn
by	by	ii
lying	lie	vvg
down	down	rp
.	.	y
The	the	at
patient	patient	nn1_jj
also	also	rr
reported	report	vvn_vvd
some	some	dd
intermittent	intermittent	jj
tinnitus	tinnitus	nn1
in	in	ii
both	both	db2
ears	ear	nn2
,	,	y
but	but	ccb
it	it	pph1
was	be	vbdz
not	not	xx
necessarily	necessarily	rr
associated	associate	vvn
with	with	iw
the	the	at
dizziness	dizziness	nn1
.	.	y
There	there	ex
was	be	vbdz
some	some	dd
underlying	underlying	jj
clogging	clogging	nn1@_vvg
in	in	ii
the	the	at
left	left	jj
ear	ear	nn1
,	,	y
but	but	ccb
no	no	at
subjective	subjective	jj
hearing	hearing	nn1
loss	loss	nn1
.	.	y
Her	her	appge
family	family	nn1
history	history	nn1
was	be	vbdz
positive	positive	jj
for	for	if
dizziness	dizziness	nn1
.	.	y
Figure	figure	vv0@_nn1
1	1	mc1
.	.	y
The	the	at
initial	initial	jj_nn1
otoacoustic	otoacoustic	jj
emissions	emission	nn2
test	test	nn1_vv0
shows	show	vvz_nn2
less	less	dar_rrr
of	of	io
a	a	at1
response	response	nn1
on	on	ii
the	the	at
left	left	jj_nn1@
.	.	y
On	on	ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
with	with	iw
either	either	dd1
foot	foot	nn1
forward	forward	rl
.	.	y
Palpation	palpation	np1@_nn1
revealed	reveal	vvd
nuchal	nuchal	jj
spasm	spasm	nn1
bilaterally	bilaterally	rr
and	and	cc
tenderness	tenderness	nn1
on	on	ii
the	the	at
left	left	jj_nn1@
.	.	y
Recent	recent	jj
audiometry	audiometry	nn1
had	have	vhd
demonstrated	demonstrate	vvn
a	a	at1
low-frequency	low-frequency	jj
,	,	y
mainly	mainly	rr
conductive	conductive	jj
hearing	hearing	nn1
decline	decline	nn1_vv0
in	in	ii
the	the	at
left	left	jj
ear	ear	nn1
with	with	iw
normal	normal	jj
tympanometry	tympanometry	nn1
.	.	y
Videonystagmography		np1@_nn1
detected	detect	vvd
a	a	at1
transient	transient	jj
left-beating	left-beating	jj_nn1
nystagmus	nystagmus	nn1
with	with	iw
the	the	at
head	head	nn1
left	leave	vvd_vvn_nn1@
.	.	y
The	the	at
patient	patient	nn1
was	be	vbdz
placed	place	vvn
on	on	ii
1	1	mc1
mg	mg	nnu
of	of	io
cyproheptadine	cyproheptadine	nn1
three	three	mc
times	time	nnt2
daily	daily	jj_rr
and	and	cc
asked	ask	vvd
to	to	to
return	return	vvi
1	1	mc1
month	month	nnt1
later	later	rrr
.	.	y
At	at	ii
her	her	appge
next	next	md
visit	visit	nn1
,	,	y
the	the	at
patient	patient	nn1
reported	report	vvd_vvn
that	that	cst
the	the	at
nausea	nausea	nn1
had	have	vhd
disappeared	disappear	vvn
and	and	cc
that	that	cst
the	the	at
headaches	headache	nn2
were	be	vbdr
diminished	diminish	vvn
,	,	y
but	but	ccb
she	she	pphs1
was	be	vbdz
experiencing	experience	vvg
even	even	rr
more	more	dar
ear	ear	nn1
pain	pain	nn1
.	.	y
Electronystagmography	electronystagmography	np1@_nn1
found	find	vvd
no	no	at
spontaneous	spontaneous	jj
or	or	cc
positional	positional	jj
nystagmus	nystagmus	nn1
.	.	y
The	the	at
alternate	alternate	jj
binaural	binaural	jj_nn1
bithermal	bithermal	jj
caloric	caloric	jj
test	test	nn1
showed	show	vvd
a	a	at1
38%	38%	nnu
reduced	reduce	vvd_vvn_jj@
vestibular	vestibular	jj
response	response	nn1
right	right	nn1
and	and	cc
a	a	at1
directional	directional	jj
preponderance	preponderance	nn1
of	of	io
54%	54%	nnu
to	to	ii
the	the	at
right	right	nn1_jj
.	.	y
The	the	at
simultaneous	simultaneous	jj
binaural	binaural	jj_nn1
bithermal	bithermal	jj
test	test	nn1
showed	show	vvd
a	a	at1
type	type	nn1
1	1	mc1
response	response	nn1
with	with	iw
no	no	at
nystagmus	nystagmus	nn1
produced	produce	vvd_vvn
.	.	y
The	the	at
sinusoidal	sinusoidal	jj
vertical-axis	vertical-axis	jj_nn1
rotation	rotation	nn1
test	test	nn1
showed	show	vvd
normal	normal	jj
gains	gain	nn2
,	,	y
a	a	at1
phase	phase	nn1
lead	lead	nn1_vv0_vvn@
at	at	ii
0.32	0.32	mc
Hz	hz	nnu
,	,	y
and	and	cc
no	no	at
abnormal	abnormal	jj
symmetry	symmetry	nn1
.	.	y
Thin-section	thin-section	jj_nn1
computed	computed	jj@_vvd_vvn
tomography	tomography	nn1
of	of	io
the	the	at
temporal	temporal	jj
bones	bone	nn2
detected	detect	vvd_vvn
evidence	evidence	nn1
of	of	io
bilateral	bilateral	jj
otosclerosis-like		jj
lesions	lesion	nn2
(	(	y
spongiotic	spongiotic	jj_nn1@
and	and	cc
sclerotic	sclerotic	jj
lesions	lesion	nn2
)	)	y
and	and	cc
pericochlear	pericochlear	vv0_nn1
lucency	lucency	nn1
.	.	y
Distortion-product	distortion-product	jj
otoacoustic	otoacoustic	jj
emissions	emission	nn2
testing	testing	nn1_vvg
showed	show	vvd
less	less	dar_rrr
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
.	.	y
The	the	at
laboratory	laboratory	nn1
evaluation	evaluation	nn1
revealed	reveal	vvd_vvn
a	a	at1
flat	flat	jj
glucose	glucose	nn1
tolerance	tolerance	nn1
test	test	nn1_vv0
with	with	iw
hyperinsulinemic	hyperinsulinemic	jj
levels	level	nn2
and	and	cc
elevated	elevated	jj_vvd
age-adjusted	age-adjusted	jj_nn1
levels	level	nn2
of	of	io
total	total	jj_nn1
cholesterol	cholesterol	nn1
(	(	y
191	191	mc
mg/dl	mg/dl	fu
)	)	y
and	and	cc
low-density	low-density	jj
lipoprotein	lipoprotein	nn1
(	(	y
LDL	ldl	nn1
)	)	y
cholesterol	cholesterol	nn1
(	(	y
124	124	mc
mg/dl	mg/dl	fu
)	)	y
.	.	y
She	she	pphs1
was	be	vbdz
placed	place	vvn
on	on	ii
a	a	at1
modified	modified	jj
hypoglycemic	hypoglycemic	jj
diet	diet	nn1
low	low	nn1@_jj_rr@
in	in	ii
fat	fat	nn1_jj
,	,	y
and	and	cc
she	she	pphs1
was	be	vbdz
prescribed	prescribe	vvn
a	a	at1
regimen	regimen	nn1
of	of	io
sodium	sodium	nn1
monofluorophosphate	monofluorophosphate	nn1
,	,	y
calcium	calcium	nn1
,	,	y
and	and	cc
vitamin	vitamin	nn1
D.	d	np1
The	the	at
cyproheptadine	cyproheptadine	nn1
was	be	vbdz
continued	continue	vvn
.	.	y
(	(	y
For	for	if
purposes	purpose	nn2
of	of	io
elucidating	elucidate	vvg
the	the	at
chronology	chronology	nn1
of	of	io
this	this	dd1
case	case	nn1
,	,	y
treatment	treatment	nn1
of	of	io
the	the	at
patient	patient	nn1
's	's	ge
symptoms	symptom	nn2
is	be	vbz
considered	consider	vvn
to	to	to
have	have	vhi
been	be	vbn
initiated	initiate	vvn
at	at	ii
this	this	dd1
second	second	nnt1_md
visit	visit	nn1_vv0
.	.	y
)	)	y
Figure	figure	nn1
2	2	mc
.	.	y
Sinusoidal	sinusoidal	jj
vertical	vertical	jj
axis	axis	nn1
rotation	rotation	nn1
at	at	ii
3	3	mc
months	month	nnt2
of	of	io
treatment	treatment	nn1
reveals	reveal	vvz
normal	normal	jj
gains	gain	nn2
,	,	y
normal	normal	jj
phases	phase	nn2
,	,	y
and	and	cc
abnormal	abnormal	jj
symmetry	symmetry	nn1
to	to	ii
the	the	at
right	right	nn1_jj
at	at	ii
0.01	0.01	mc
and	and	cc
0.04	0.04	mc
Hz	hz	nnu
.	.	y
Three	three	mc
months	month	nnt2
later	later	rrr
,	,	y
she	she	pphs1
returned	return	vvd
and	and	cc
reported	report	vvd_vvn
that	that	cst
her	her	appge
headaches	headache	nn2
had	have	vhd
disappeared	disappear	vvn
altogether	altogether	rr
and	and	cc
that	that	cst
her	her	appge
nausea	nausea	nn1
had	have	vhd
not	not	xx
recurred	recur	vvn
.	.	y
However	however	rr
,	,	y
she	she	pphs1
complained	complain	vvd
of	of	io
some	some	dd
bilateral	bilateral	jj
neck	neck	nn1
to	to	to
shoulder	shoulder	vvi
pain	pain	nn1
while	while	cs
lying	lie	vvg
down	down	rp
and	and	cc
associated	associated	jj
ear	ear	nn1
pain	pain	nn1
.	.	y
Her	her	appge
dizziness	dizziness	nn1
was	be	vbdz
"	"	y
not	not	xx
really	really	rr
too	too	rg
bad	bad	jj
,	,	y
"	"	y
occurring	occur	vvg
occasionally	occasionally	rr
when	when	cs_rrq
she	she	pphs1
got	get	vvd
into	into	ii
and	and	cc
out	out	ii21
of	of	ii22
bed	bed	nn1
.	.	y
She	she	pphs1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
when	when	rrq_cs
she	she	pphs1
felt	feel	vvd
dizzy	dizzy	jj
while	while	cs
lying	lie	vvg
down	down	rp
.	.	y
She	she	pphs1
had	have	vhd
complied	comply	vvn
with	with	iw
her	her	appge
diet	diet	nn1
"	"	y
more	more	rrr_rgr
or	or	cc
less	less	rrr_dar
,	,	y
"	"	y
and	and	cc
her	her	appge
total	total	jj_nn1
cholesterol	cholesterol	nn1
and	and	cc
LDL	ldl	nn1
cholesterol	cholesterol	nn1
levels	level	nn2
fell	fall	vvd
slightly	slightly	rr
to	to	ii
184	184	mc
and	and	cc
121	121	mc
mg/dl	mg/dl	fu
,	,	y
respectively	respectively	rr
.	.	y
A	a	at1_zz1
2-hour	2-hour	jj
glucose	glucose	nn1
tolerance	tolerance	nn1
test	test	nn1_vv0
again	again	rt
showed	show	vvd
flat	flat	jj
responses	response	nn2
,	,	y
and	and	cc
her	her	appge
insulin	insulin	nn1
level	level	nn1
had	have	vhd
decreased	decrease	vvn
.	.	y
Sinusoidal	sinusoidal	jj
vertical-axis	vertical-axis	jj_nn1
rotation	rotation	nn1
testing	testing	nn1
showed	show	vvd
normal	normal	jj
gains	gain	nn2
and	and	cc
normal	normal	jj
phases	phase	nn2
;	;	y
the	the	at
latter	latter	da
represented	represent	vvd_vvn
an	a	at1
improvement	improvement	nn1
over	over	ii
the	the	at
previous	previous	jj
test	test	nn1
,	,	y
indicating	indicate	vvg
that	that	cst
a	a	at1
shift	shift	nn1@
in	in	ii
peripheral	peripheral	jj
vestibular	vestibular	jj
function	function	nn1
had	have	vhd
occurred	occur	vvn
(	(	y
figure	figure	nn1
2	2	mc
)	)	y
.	.	y
There	there	ex
was	be	vbdz
abnormal	abnormal	jj
symmetry	symmetry	nn1
to	to	ii
the	the	at
right	right	nn1_jj
at	at	ii
0.01	0.01	mc
and	and	cc
0.04	0.04	mc
Hz	hz	nnu
,	,	y
which	which	ddq
indicated	indicate	vvd
incomplete	incomplete	jj
central	central	jj
vestibular	vestibular	jj
compensation	compensation	nn1
of	of	io
the	the	at
improved	improved	jj
vestibular	vestibular	jj
function	function	nn1
.	.	y
Otoacoustic	otoacoustic	jj
emissions	emission	nn2
testing	test	vvg_nn1
revealed	revealed	jj@_vvd_vvn
improved	improved	jj
responses	response	nn2
in	in	ii
the	the	at
left	left	jj
ear	ear	nn1
(	(	y
figure	figure	nn1
3	3	mc
)	)	y
.	.	y
Her	her	appge
current	current	jj
treatment	treatment	nn1
was	be	vbdz
continued	continue	vvn
.	.	y
Figure	figure	nn1
3	3	mc
.	.	y
Otoacoustic	otoacoustic	jj
emissions	emission	nn2
testing	test	vvg
at	at	ii
3	3	mc
months	month	nnt2
reveals	reveal	vvz
improved	improved	jj
responses	response	nn2
in	in	ii
the	the	at
left	left	jj
ear	ear	nn1
.	.	y
She	she	pphs1
returned	return	vvd
10	10	mc
months	month	nnt2
into	into	ii
treatment	treatment	nn1
and	and	cc
reported	report	vvd_vvn
no	no	at
aural	aural	jj
fullness	fullness	nn1
,	,	y
ear	ear	nn1
pain	pain	nn1
,	,	y
dizziness	dizziness	nn1
,	,	y
nausea	nausea	nn1
,	,	y
headache	headache	nn1
,	,	y
neck	neck	nn1_vv0@
ache	ache	nn1_vv0
,	,	y
or	or	cc
tinnitus	tinnitus	nn1_jj
.	.	y
Her	her	appge
elevated	elevated	jj
serum	serum	nn1
cholesterol	cholesterol	nn1
levels	level	nn2
remained	remain	vvd
the	the	at
same	same	da
.	.	y
A	a	at1_zz1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
normal	normal	jj
phases	phase	nn2
,	,	y
and	and	cc
her	her	ppho1_appge
previously	previously	rr
abnormal	abnormal	jj
symmetry	symmetry	nn1
improved	improve	vvn_vvd
into	into	ii
the	the	at
normal	normal	jj
range	range	nn1
,	,	y
but	but	ccb
the	the	at
previous	previous	jj
findings	finding	nn2
at	at	ii
0.16	0.16	mc
and	and	cc
0.32	0.32	mc
Hz	hz	nnu
had	have	vhd
migrated	migrate	vvn
into	into	ii
the	the	at
abnormal	abnormal	jj
range	range	nn1
and	and	cc
to	to	ii
the	the	at
right	right	nn1_jj
.	.	y
Her	her	appge
regimen	regimen	nn1
of	of	io
sodium	sodium	nn1
monofluorophosphate	monofluorophosphate	nn1
,	,	y
calcium	calcium	nn1
,	,	y
and	and	cc
vitamin	vitamin	nn1
D	d	zz1_np1@
was	be	vbdz
continued	continue	vvn_jj
,	,	y
and	and	cc
her	her	appge
dietary	dietary	jj
management	management	nn1
was	be	vbdz
passed	pass	vvn
on	on	ii21_rp
to	to	ii22_ii
her	her	appge
pediatrician	pediatrician	nn1
.	.	y
She	she	pphs1
returned	return	vvd
18	18	mc
months	month	nnt2
into	into	ii
the	the	at
treatment	treatment	nn1
and	and	cc
remained	remain	vvd_vvn
completely	completely	rr
asymptomatic	asymptomatic	jj
.	.	y
Her	her	appge
dietary	dietary	jj
compliance	compliance	nn1
had	have	vhd
waned	wane	vvn
since	since	cs_ii@
her	her	appge
previous	previous	jj
visit	visit	nn1
.	.	y
Sinusoidal	sinusoidal	jj
vertical-axis	vertical-axis	jj_nn1
rotation	rotation	nn1
testing	testing	nn1_vvg
continued	continue	vvd_vvn_jj
to	to	to
show	show	vvi
normal	normal	jj
gains	gain	nn2
and	and	cc
phases	phase	nn2
;	;	y
the	the	at
previous	previous	jj
abnormal	abnormal	jj
symmetry	symmetry	nn1
reverted	revert	vvn_vvd
to	to	ii
normal	normal	jj
,	,	y
and	and	cc
the	the	at
previous	previous	jj
finding	finding	nn1
at	at	ii
0.01	0.01	mc
Hz	hz	nnu
became	become	vvd
abnormal	abnormal	jj
right	right	nn1
(	(	y
figure	figure	nn1
4	4	mc
)	)	y
.	.	y
Figure	figure	nn1
4	4	mc
.	.	y
Sinusoidal	sinusoidal	jj
vertical-axis	vertical-axis	jj_nn1
rotation	rotation	nn1
testing	test	vvg_nn1
at	at	ii
18	18	mc
months	month	nnt2
shows	show	vvz
normal	normal	jj
gains	gain	nn2
,	,	y
normal	normal	jj
phases	phase	nn2
,	,	y
and	and	cc
improvement	improvement	nn1
in	in	ii
symmetry	symmetry	nn1
.	.	y
This	this	dd1
case	case	nn1
illustrates	illustrate	vvz
several	several	da2
clinical	clinical	jj
points	point	nn2
.	.	y
First	first	md
,	,	y
children	child	nn2
may	may	vm
present	present	vvi
with	with	iw
neurotologic	neurotologic	jj
symptoms	symptom	nn2
caused	cause	vvn
by	by	ii
early-onset	early-onset	jj
otosclerosis-like		jj
lesions	lesion	nn2
of	of	io
the	the	at
otic	otic	jj
capsule	capsule	nn1
.	.	y
Symptoms	symptom	nn2
of	of	io
this	this	dd1
nature	nature	nn1
are	be	vbr
unusual	unusual	jj
in	in	ii
this	this	dd1
age	age	nn1
group	group	nn1
,	,	y
and	and	cc
otosclerosis	otosclerosis	nn1
as	as	ii_csa
an	a	at1
etiology	etiology	nn1
is	be	vbz
rare	rare	jj
.	.	y
In	in	ii
this	this	dd1
case	case	nn1
,	,	y
the	the	at
patient	patient	nn1
's	's	ge
abnormality	abnormality	nn1
was	be	vbdz
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
by	by	ii
rotation	rotation	nn1
testing	testing	nn1_vvg
.	.	y
This	this	dd1
circumstance	circumstance	nn1
highlights	highlight	vvz
the	the	at
importance	importance	nn1
of	of	io
performing	perform	vvg
both	both	db2
tests	test	nn2
of	of	io
vestibular	vestibular	jj
function	function	nn1
.	.	y
The	the	at
rotation	rotation	nn1
test	test	nn1
was	be	vbdz
delayed	delay	vvn
compared	compare	vvn
with	with	iw
electronystagmography	electronystagmography	nn1
in	in	ii
demonstrating	demonstrate	vvg
a	a	at1
vestibular	vestibular	jj
abnormality	abnormality	nn1
,	,	y
and	and	cc
the	the	at
rotation	rotation	nn1
test	test	nn1_vv0
findings	finding	nn2
remained	remain	vvd_vvn
abnormal	abnormal	jj
even	even	rr
as	as	csa_ii
the	the	at
patient	patient	nn1
's	's	ge
symptoms	symptom	nn2
abated	abate	vvd_vvn
.	.	y
A	a	at1
second	second	md_nnt1
important	important	jj
clinical	clinical	jj
point	point	nn1
is	be	vbz
that	that	cst_dd1
while	while	cs
this	this	dd1
child	child	nn1
demonstrated	demonstrate	vvd_vvn
normal	normal	jj
hearing	hearing	nn1
to	to	ii
20	20	mc
kHz	khz	nnu
,	,	y
she	she	pphs1
showed	show	vvd
abnormal	abnormal	jj
otoacoustic	otoacoustic	jj
emissions	emission	nn2
before	before	ii
beginning	begin	vvg
treatment	treatment	nn1
.	.	y
This	this	dd1
abnormality	abnormality	nn1
resolved	resolve	vvd_vvn
early	early	rr_jj
during	during	ii
treatment	treatment	nn1
.	.	y
Third	third	md
,	,	y
the	the	at
search	search	nn1
for	for	if
answers	answer	nn2
to	to	ii
vestibular	vestibular	jj
problems	problem	nn2
by	by	ii
looking	look	vvg
for	for	if
metabolic	metabolic	jj
abnormalities	abnormality	nn2
led	lead	vvn_vvd
to	to	ii
the	the	at
discovery	discovery	nn1
of	of	io
abnormal	abnormal	jj
levels	level	nn2
of	of	io
both	both	db2
blood	blood	nn1_vv0%
glucose	glucose	nn1
and	and	cc
lipids	lipids	nn2
.	.	y
But	but	ccb
the	the	at
patient	patient	nn1
's	's	ge
good	good	jj
response	response	nn1
to	to	ii
the	the	at
otosclerosis	otosclerosis	nn1
treatment	treatment	nn1
made	make	vvd_vvn
it	it	pph1
seemingly	seemingly	rr
less	less	rgr
urgent	urgent	jj
to	to	to
comply	comply	vvi
with	with	iw
recommended	recommended	jj@
diet	diet	nn1
and	and	cc
lifestyle	lifestyle	nn1
changes	change	nn2
.	.	y
Finding	find	vvg
metabolic	metabolic	jj
abnormalities	abnormality	nn2
and	and	cc
getting	get	vvg
the	the	at
cooperation	cooperation	nn1
of	of	io
the	the	at
parents	parent	nn2
,	,	y
pediatricians	pediatrician	nn2
,	,	y
and	and	cc
patients	patient	nn2
in	in	ii
treating	treat	vvg
them	them	ppho2
are	be	vbr
likely	likely	jj
to	to	to
prevent	prevent	vvi
future	future	jj_nn1
health	health	nn1
problems	problem	nn2
.	.	y
Since	since	cs_rr@
full	full	jj
bone	bone	nn1
growth	growth	nn1
does	do	vdz
not	not	xx
occur	occur	vvi
until	until	cs_ii@
patients	patient	nn2
reach	reach	vv0
the	the	at
age	age	nn1
of	of	io
18	18	mc
to	to	ii
20	20	mc
years	year	nnt2
,	,	y
the	the	at
use	use	nn1
of	of	io
bisphosphonates	bisphosphonate	nn2
in	in	ii
children	child	nn2
is	be	vbz
contraindicated	contraindicate	vvn@_jj@
.	.	y
Fourth	fourth	md
,	,	y
the	the	at
sinusoidal	sinusoidal	jj
vertical-axis	vertical-axis	jj_nn1
rotation	rotation	nn1
test	test	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
asymptomatic	asymptomatic	jj
.	.	y
This	this	dd1
finding	finding	nn1
suggests	suggest	vvz
that	that	rg
early	early	rr
discontinuation	discontinuation	nn1
of	of	io
treatment	treatment	nn1
could	could	vm
have	have	vhi
resulted	result	vvn
in	in	ii
a	a	at1
recurrence	recurrence	nn1
of	of	io
symptoms	symptom	nn2
.	.	y
Finally	finally	rr
,	,	y
a	a	at1
young	young	jj
girl	girl	nn1
in	in	ii
such	such	da
a	a	at1
situation	situation	nn1
may	may	vm
experience	experience	vvi
a	a	at1
recurrence	recurrence	nn1
of	of	io
symptoms	symptom	nn2
driven	drive	vvn
by	by	ii
menarche	menarche	nn1
.	.	y
By	by	ii
Kenneth	kenneth	np1
H.	h	np1
Brookler	brookler	np1
,	,	y
MD	md	nna
,	,	y
MS	ms	nn1
,	,	y
FRCSC	frcsc	np1
,	,	y
From	from	ii
Neurotologic	neurotologic	jj
Associates	associate	nn2
,	,	y
PC	pc	nn1
,	,	y
New	new	np1
York	york	np1
City	city	nn1
